Senior insider sale
Chief Medical Officer at TRAVERE THERAPEUTICS, INC. — senior position signals high conviction
$583.2K
15.95K shares
What this filing means
INRIG JULA plans to sell 15.95K shares of TRAVERE THERAPEUTICS, INC. valued at approximately $583.2K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 4/15/2026ACC: 0001193125-26-155560
Officer· Chief Medical Officer
Since Jan 2022
15.95K
Shares to sell
$583.2K
Approx. market value
7.21K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Performance Restricted Stock Unit Vesting
Compensation
4/13/2026
7.21KTotal acquired7.21K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
4/13/2026 | Performance Restricted Stock Unit Vesting Compensation | 7.21K | — |
| Total | 7.21K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
1.78K
Market value
$57.3K
2/4/2026
—Completed
Units to sell
6.96K
Market value
$223.4K
2/3/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
7.21K
Market value
$302.5K
4/14/2026
Total
Units
15.95K
Value
$583.2K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
2/4/2026 | 1.78K | $57.3K | — | Completed |
2/3/2026 | 6.96K | $223.4K | — | Completed |
| Planned — Approximate Date | ||||
4/14/2026 | 7.21K | $302.5K | NASDAQ | Planned |
| Total | 15.95K | $583.2K | ||